0 items USD 0.00Search
Your search for "delveinsight prostate cancer global api manufacturers marketed phase iii drugs landscape 2015" gave back 688394 results.
A molecular approach for diagnosing prostate cancer Market Analysis and Insights: Global Prostate Cancer Molecular Diagnostics Market The global...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes. Market Analysis and...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Rucaparib API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy,...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Cryotherapy Ablation Device market size was valued at USD 135.6 million in 2023 and is forecast to a readjusted size of USD 621.4 million...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. Anticancer drugs are...
Catalog:
LPI
May 2024
Price: USD 3,660.00
The global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Benign Prostatic Hyperplasia (BPH) Drugs market size was valued at US$ 3257.1 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Small Molecule Cancer Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Cytotoxic Drug market size was valued at US$ 14360 million in 2023. With growing demand in downstream market, the Cytotoxic Drug is...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
